Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Data: The Ethereum spot ETF had a total net inflow of 0 US dollars yesterday, and all 9 ETH ETFs had no inflows or outflows

Data: The Ethereum spot ETF had a total net inflow of 0 US dollars yesterday, and all 9 ETH ETFs had no inflows or outflows

Bitget2024/11/06 05:50

According to SoSoValue data, as of yesterday (Eastern Time November 5), the net outflow of Ethereum spot ETF was $0.00.

Yesterday, Grayscale's Ethereum Trust ETF ETHE had a single-day net outflow of $0.00, and the current historical net outflow of ETHE is $3.142 billion. Grayscale's Mini Ethereum Trust ETF ETH had a single-day net outflow of $0.00, and the total historical net inflow for Grayscale's Mini Ethereum Trust ETH is currently at $271 million.

As of press time, the net asset value of the Ethereum spot ETF is $6.639 billion, with an ETF Net Asset Ratio (the ratio compared to the total market value) reaching 2.27%. The cumulative historical net outflows have reached $555 million.

1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss